/PRNewswire/ HanAll Biopharma (KRX: 009420.KS) announced today the appointment of Almira Chabi, M.D. as Chief Medical Officer and Chief Development Officer.
/PRNewswire/ HanAll Biopharma (KRX: 009420.KS) announced today the appointment of Almira Chabi, M.D. as Chief Medical Officer and Chief Development Officer.
HanAll Biopharma Appoints Almira Chabi as Chief Medical Officer and Chief Development Officer - read this article along with other careers information, tips and advice on BioSpace